Company intelligence / Profile preview

Quigley Pharma Inc.

Doylestown, Pennsylvania, United Statesquigleypharma.com ↗
Ownership
Private
Development stage
Other
01

Overview

Quigley Pharma conducted research on natural-source prescription medicinals. It had conducted one positive pre-clinical in vitro study on Avian Flu, demonstrating antiviral activity. The company was working on products for conditions such as diabetic peripheral neuropathy, radiation dermatitis, and influenza.

Therapeutic areas
EndocrinologyDermatologyOtherOncologyNeurologyInfectious Diseases
Modalities
Natural-source prescription medicinals
Industry
Biotech
02

Drug pipeline

9 assets

QR-333

2

8 more assets in the full pipeline.

Beyond the preview

Go deeper on Quigley Pharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quigley Pharma Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call